These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1177 related items for PubMed ID: 8642263
1. Human Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes home preferentially to and induce selective regressions of autologous EBV-induced B cell lymphoproliferations in xenografted C.B-17 scid/scid mice. Lacerda JF, Ladanyi M, Louie DC, Fernandez JM, Papadopoulos EB, O'Reilly RJ. J Exp Med; 1996 Mar 01; 183(3):1215-28. PubMed ID: 8642263 [Abstract] [Full Text] [Related]
2. Administration of rabbit anti-asialo GM1 antiserum facilitates the development of human Epstein-Barr virus-induced lymphoproliferations in xenografted C.B-17 scid/scid mice. Lacerda JF, Ladanyi M, Jagiello C, O'Reilly RJ. Transplantation; 1996 Feb 15; 61(3):492-7. PubMed ID: 8610366 [Abstract] [Full Text] [Related]
3. Characteristics of human EBV-specific cytotoxic T lymphocytes utilized for adoptive immunotherapy of EBV-induced lymphoproliferations in xenografted SCID mice. Lacerda JF, O'Reilly RJ. Ann Oncol; 1997 Feb 15; 8 Suppl 2():137-40. PubMed ID: 9209657 [Abstract] [Full Text] [Related]
4. Adoptive transfer of cytotoxic T lymphocytes for the treatment of transplant-associated lymphoma. Boyle TJ, Berend KR, DiMaio JM, Coles RE, Via DF, Lyerly HK. Surgery; 1993 Aug 15; 114(2):218-25; discussion 226. PubMed ID: 8393595 [Abstract] [Full Text] [Related]
5. Use of Epstein-Barr virus-transformed, autologous B-lymphoblastoid cells as antigen-presenting cells for establishment and maintenance of dengue virus-specific, human cytotoxic T lymphocyte clones. Livingston PG, Kurane I, Ennis FA. J Virol Methods; 1997 Aug 15; 67(1):77-84. PubMed ID: 9274820 [Abstract] [Full Text] [Related]
6. Composite response of naive T cells to stimulation with the autologous lymphoblastoid cell line is mediated by CD4 cytotoxic T cell clones and includes an Epstein-Barr virus-specific component. Misko IS, Sculley TB, Schmidt C, Moss DJ, Soszynski T, Burman K. Cell Immunol; 1991 Feb 15; 132(2):295-307. PubMed ID: 1846323 [Abstract] [Full Text] [Related]
8. Assessment and characterization of the cytolytic T lymphocyte response against Epstein-Barr virus in patients with non-Hodgkin's lymphoma after autologous peripheral blood stem cell transplantation. Nolte A, Buhmann R, Straka C, Emmerich B, Hallek M. Bone Marrow Transplant; 1998 May 15; 21(9):909-16. PubMed ID: 9613783 [Abstract] [Full Text] [Related]
9. Class I major histocompatibility complex-restricted cytotoxic T lymphocytes specific for Epstein-Barr virus (EBV)-transformed B lymphoblastoid cell lines against which they were raised. Hill AB, Lee SP, Haurum JS, Murray N, Yao QY, Rowe M, Signoret N, Rickinson AB, McMichael AJ. J Exp Med; 1995 Jun 01; 181(6):2221-8. PubMed ID: 7539044 [Abstract] [Full Text] [Related]
10. EBV-specific cytotoxic T lymphocytes protect against human EBV-associated lymphoma in scid mice. Buchsbaum RJ, Fabry JA, Lieberman J. Immunol Lett; 1996 Sep 01; 52(2-3):145-52. PubMed ID: 8905410 [Abstract] [Full Text] [Related]
11. Down-regulation of class I HLA antigens and of the Epstein-Barr virus-encoded latent membrane protein in Burkitt lymphoma lines. Masucci MG, Torsteindottir S, Colombani J, Brautbar C, Klein E, Klein G. Proc Natl Acad Sci U S A; 1987 Jul 01; 84(13):4567-71. PubMed ID: 3037521 [Abstract] [Full Text] [Related]